Current Issue

Category: 2026

Effects of combined metformin and cabergoline versus metformin alone on inflammatory markers in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial

Hamad Inas Naser et al.
2026
Issue 5
pp 359 - 365
DOI: 10.25122/jml-2026-0012

Polycystic ovarian syndrome (PCOS) is by far the most prevalent metabolic disease affecting women during their reproductive life. Obesity is a frequently associated manifestation of polycystic ovary syndrome. Central body fat...

View Article Download PDF

Categories